Analysis of patient samples collected during the enrollment of the Warfarin in Antiphospholipid Syndrome (WAPS) study revealed that individuals testing positive for LA and β2GPI exhibited an increased risk of overall thrombosis. The gene discussed is APOH; the disease is deep vein thrombosis.